Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology(2023)

引用 1|浏览2
暂无评分
摘要
•The incidence of symptomatic radionecrosis is higher when combining T-DM1 and brain RT compared to radiotherapy alone.•The combination of T-DM1 and locoregional RT for non-metastatic disease is associated with a low rate of side effects.•The combination of T-DM1 and RT shows safety in terms of acute skin effects and pneumonitis.•The field is currently awaiting international consensus recommendations.
更多
查看译文
关键词
concurrent radiation therapy,radiation therapy,trastuzumab-emtansine,meta-analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要